{"id":3081,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2015-11-11","marketCap":508.796875,"name":"Voyager Therapeutics Inc","phone":"18572595340","outstanding":53.91999816894531,"symbol":"VYGR","website":"https://www.voyagertherapeutics.com/","industry":"Biotechnology"},"price":9.5575,"year":2024,"month":3,"day":9,"weekday":"Saturday","title":"Sentiment Analysis on Voyager Therapeutics Inc Stock","date":"2024-03-09","url":"/posts/2024/03/09/VYGR","content":[{"section":"Analyst Opinions","text":"A majority of analysts have a positive sentiment towards Voyager Therapeutics Inc stock. Many analysts view the company's gene therapy platform and pipeline as promising, which has resulted in favorable price targets and recommendations."},{"section":"Price Targets","text":"Several analysts have provided price targets for Voyager Therapeutics Inc stock. The average price target is $27.50, with a high estimate of $35 and a low estimate of $20. These price targets suggest potential upside for the stock in the future."},{"section":"Recommendations","text":"Most analysts recommend buying or holding Voyager Therapeutics Inc stock. Some analysts have issued buy ratings based on the company's strong pipeline and potential for successful gene therapies. However, it is important to consider individual risk tolerance and conduct personal due diligence before making investment decisions."}],"tags":["CrossOver21","Long","Biotechnology"],"news":[{"category":"company","date":1709911500,"headline":"Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier","id":126406227,"image":"https://media.gettyimages.com/id/1181606267/photo/3d-rendering-of-a-plastic-jar-with-medical-pills-on-a-hand-truck-on-blue-background.jpg?b=1\u0026s=170667a\u0026w=0\u0026k=20\u0026c=mXJp1VzWAVvyjFs7z6lIW4UxwHdkidu_J7cQMrN1TTU=","symbol":"VYGR","publisher":"SeekingAlpha","summary":"Voyager Therapeutics investors need to be patient as the biotech targets hard to treat Alzheimer's and Parkinson's. Read why the best days are ahead for VYGR stock.","url":"https://seekingalpha.com/article/4677071-voyager-therapeutics-a-tortoise-with-a-shot-at-making-gene-therapy-deliver-easier"},{"category":"company","date":1709698560,"headline":"Voyager Therapeutics: A Strong Buy on CNS Gene Therapy Advances and Strategic Partnerships","id":126383901,"image":"","symbol":"VYGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3385312503"},{"category":"company","date":1709697960,"headline":"Voyager Therapeutics initiated with bullish view at Citi, here's why","id":126383902,"image":"","symbol":"VYGR","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3385294046"},{"category":"company","date":1709619960,"headline":"Voyager Therapeutics (VYGR) Receives a Rating Update from a Top Analyst","id":126340426,"image":"","symbol":"VYGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3382659858"},{"category":"company","date":1709548377,"headline":"Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts","id":126296704,"image":"https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","symbol":"VYGR","publisher":"Yahoo","summary":"Today is shaping up negative for Voyager Therapeutics, Inc. ( NASDAQ:VYGR ) shareholders, with the analysts delivering...","url":"https://finance.yahoo.com/news/analysts-just-made-major-revision-103257766.html"},{"category":"company","date":1709295540,"headline":"Voyager Therapeutics’ Promising Outlook in Gene Therapy: A Strong Buy Recommendation","id":126247452,"image":"","symbol":"VYGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3376341988"},{"category":"company","date":1709275740,"headline":"Oppenheimer Sticks to Their Buy Rating for Voyager Therapeutics (VYGR)","id":126247453,"image":"","symbol":"VYGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3376664580"},{"category":"company","date":1709265540,"headline":"Voyager Therapeutics Buy Rating Affirmed Amid Strong Pipeline and Financial Health","id":126247454,"image":"","symbol":"VYGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3376506033"},{"category":"company","date":1709222957,"headline":"Q4 2023 Voyager Therapeutics Inc Earnings Call","id":126221794,"image":"","symbol":"VYGR","publisher":"Yahoo","summary":"Q4 2023 Voyager Therapeutics Inc Earnings Call","url":"https://finance.yahoo.com/news/q4-2023-voyager-therapeutics-inc-160917595.html"},{"category":"company","date":1709218454,"headline":"Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript","id":126221795,"image":"https://s.yimg.com/ny/api/res/1.2/dc9PCG1g_QuTADxf7V52Pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/5b07936417f70dda1c0c9f6de536091a","symbol":"VYGR","publisher":"Yahoo","summary":"Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript February 28, 2024 Voyager Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.25, expectations were $-0.59. Voyager Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. Thank you […]","url":"https://finance.yahoo.com/news/voyager-therapeutics-inc-nasdaq-vygr-145414224.html"},{"category":"company","date":1709202720,"headline":"Voyager Therapeutics Shares Rise 15% After 4Q Swing to Profit","id":126214025,"image":"https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png","symbol":"VYGR","publisher":"MarketWatch","summary":"By Chris Wack Voyager Therapeutics shares were up 15% to $10.05 after the company swung to a fourth-quarter profit, while analysts were expecting a loss. The...","url":"https://www.marketwatch.com/story/voyager-therapeutics-shares-rise-15-after-4q-swing-to-profit-eff4da4d"},{"category":"company","date":1709194980,"headline":"Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge","id":126199070,"image":"","symbol":"VYGR","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3374525062"},{"category":"company","date":1709190360,"headline":"Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket","id":126200179,"image":"","symbol":"VYGR","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3374408615"},{"category":"company","date":1709190120,"headline":"Analysts Conflicted on These Healthcare Names: Immunocore Holdings (IMCR), Voyager Therapeutics (VYGR) and Castle Biosciences (CSTL)","id":126203031,"image":"","symbol":"VYGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3374403604"},{"category":"company","date":1709188140,"headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday","id":126199281,"image":"","symbol":"VYGR","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3374357582"},{"category":"company","date":1709161330,"headline":"Voyager Therapeutics, Inc. (VYGR) Q4 2023 Earnings Call Transcript","id":126185580,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"VYGR","publisher":"SeekingAlpha","summary":"Voyager Therapeutics, Inc. (NASDAQ:NASDAQ:VYGR) Q4 2023 Results Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPeter Pfreundschuh...","url":"https://seekingalpha.com/article/4674631-voyager-therapeutics-inc-vygr-q4-2023-earnings-call-transcript"},{"category":"company","date":1709156515,"headline":"Voyager Therapeutics Inc (VYGR) Announces Strong Year-End Financials with Significant Cash Position","id":126187638,"image":"","symbol":"VYGR","publisher":"Yahoo","summary":"Pro-Forma Cash of $431 Million Sets Stage for Clinical Advancements into 2027","url":"https://finance.yahoo.com/news/voyager-therapeutics-inc-vygr-announces-214155031.html"},{"category":"company","date":1709154060,"headline":"Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results","id":126187639,"image":"","symbol":"VYGR","publisher":"Yahoo","summary":"- Company had approximately $431 million in pro-forma cash as of December 31, 2023, adjusted for $100 million consideration from Novartis agreements and $100 million public offering - - Strong cash position and anticipated milestones/reimbursements provide runway into 2027, potentially enabling the generation of clinical data from multiple programs - - Lead development candidates selected in Friedreich’s ataxia gene therapy program in collaboration with Neurocrine Biosciences, triggering $5 mill","url":"https://finance.yahoo.com/news/voyager-therapeutics-reports-fourth-quarter-210100415.html"},{"category":"company","date":1709138054,"headline":"Voyager Therapeutics: Q4 Earnings Snapshot","id":126182610,"image":"","symbol":"VYGR","publisher":"Finnhub","summary":"LEXINGTON, Mass. — LEXINGTON, Mass. — Voyager Therapeutics Inc. on Wednesday reported fourth-quarter net income of $56.4 million. The Lexington, Massachusetts-based company said it had...","url":"https://finnhub.io/api/news?id=7c878cdb913b656c7947f96c7c5706512e94cb27d0d825faf1c6da86c734428a"},{"category":"company","date":1709103540,"headline":"Fly Intel: After-Hours Movers","id":126203449,"image":"","symbol":"VYGR","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3373469683"},{"category":"company","date":1709098080,"headline":"Earnings Scheduled For February 28, 2024","id":126199193,"image":"","symbol":"VYGR","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3372089340"},{"category":"company","date":1709097060,"headline":"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Warby Parker (WRBY)","id":126222460,"image":"","symbol":"VYGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3373241276"},{"category":"company","date":1709095800,"headline":"WW, DUOL and VYGR are among after hour movers","id":126216494,"image":"","symbol":"VYGR","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3373197039"},{"category":"company","date":1709091180,"headline":"Voyager Therapeutics: Q4 Earnings Insights","id":126222743,"image":"","symbol":"VYGR","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3373039423"},{"category":"company","date":1709091180,"headline":"12 Health Care Stocks Moving In Wednesday's After-Market Session","id":126203072,"image":"","symbol":"VYGR","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3373039417"},{"category":"company","date":1709090460,"headline":"Voyager Therapeutics reports Q4 EPS $1.25, consensus (29c)","id":126222745,"image":"","symbol":"VYGR","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3373015094"},{"category":"company","date":1709089620,"headline":"Voyager Therapeutics GAAP EPS of $1.25 beats by $1.54, revenue of $90.06M beats by $69.42M","id":126222747,"image":"","symbol":"VYGR","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3372987704"},{"category":"company","date":1709035380,"headline":"Earnings Preview For Voyager Therapeutics","id":126222748,"image":"","symbol":"VYGR","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3370538424"},{"category":"company","date":1709023008,"headline":"Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich's Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment","id":126162326,"image":"","symbol":"VYGR","publisher":"Finnhub","summary":"LEXINGTON - Voyager Therapeutics, Inc. , a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the joint steering committee with its collaborator Neurocrine...","url":"https://finnhub.io/api/news?id=aa9b36d6f9539a55c594c96fcb160fff5e6c8230f3e4f42761837785c068affa"},{"category":"company","date":1709004960,"headline":"VYGR Makes Bullish Cross Above Critical Moving Average","id":126222750,"image":"","symbol":"VYGR","publisher":"Market News Video","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3370890384"},{"category":"company","date":1708948800,"headline":"Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment","id":126134306,"image":"https://media.zenfs.com/en/globenewswire.com/7893caf0c53927eddc24174c008913fb","symbol":"VYGR","publisher":"Yahoo","summary":"LEXINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the joint steering committee with its collaborator Neurocrine Biosciences has selected a lead development candidate in the Friedreich’s ataxia (FA) program. The candidate combines a frataxin (FXN) gene replacement payload with an intravenously administered, blood-brain barrier penetrant, novel capsid derived fro","url":"https://finance.yahoo.com/news/voyager-therapeutics-announces-selection-gene-120000459.html"},{"category":"company","date":1708933560,"headline":"Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?","id":126132595,"image":"https://media.zenfs.com/en/zacks.com/c57dbafbfe115dbdb95d6f312af81f7e","symbol":"VYGR","publisher":"Yahoo","summary":"Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.","url":"https://finance.yahoo.com/news/novavax-nvax-surges-8-4-074600511.html"},{"category":"company","date":1708928220,"headline":"Voyager Therapeutics reports selection of gene therapy development candidate","id":126142637,"image":"","symbol":"VYGR","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3368038061"},{"category":"company","date":1708914300,"headline":"7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff","id":126144480,"image":"","symbol":"VYGR","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3368733050"}]}